Essential Diabetes and Asthma Drug List ~ NRS 439B.630
Senate Bill No. 539 was passed during the 2017 legislative session,
requiring the Department to compile a list of prescription drugs that the
Department determines to be essential for treating diabetes in this State and
the wholesale acquisition cost of each drug on the list. Effective May 30,
2019, Senate Bill No. 262 builds on Nevada’s diabetes drug pricing transparency
law by including asthma drugs. The list must include, without limitation, all
forms of insulin and biguanides marketed for sale in this State. Senate Bill
No. 380 passed during the 2021 legislative session, removing asthma medications
and adding any medication that costs over $40 for a course of therapy that also
experienced a significant price increase.